Infliximab trough level measured during treatment induction may be predictive of the loss of response to Infliximab during treatment maintenance in inflammatory bowel disease patients: a longitudinal observational retrospective study

被引：0
|
作者：
Liefferinckx, C. [1 ]
Minsart, C. [2 ]
Cremer, A. [1 ]
Amininejad, L. [1 ]
Toubeau, J. -F. [3 ]
Quertinmont, E. [2 ]
Deviere, J. [1 ]
Van Gossum, A. [1 ]
Franchimont, D. [1 ]
机构：
[1] Free Univ Brussels, Erasme Hosp, Gastroenterol, B-1050 Brussels, Belgium
[2] Univ Libre Bruxelles, Lab Expt Gastroenterol, Brussels, Belgium
[3] Univ Mons, Dept Elect Engn, B-7000 Mons, Belgium
来源：
JOURNAL OF CROHNS & COLITIS | 2016年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P405
引用
收藏
页码：S303 / S304
页数：2
相关论文
共 50 条
  • [41] Predictive value of infliximab trough levels in maintenance therapy for 5-year sustained clinical remission in patients with inflammatory bowel disease
    Jalali, Yashar
    Gojdicova, Anna
    Sturdik, Igor
    Toth, Jozef
    Koller, Tomas
    Huorka, Martin
    Jalali, Monika
    Payer, Juraj
    Hlavaty, Tibor
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2023, 124 (07): : 485 - 492
  • [42] Serum trough infliximab levels: A comparison of three different immunoassays for the monitoring of CT-P13 (infliximab) treatment in patients with inflammatory bowel disease
    Malickova, Karin
    Duricova, Dana
    Bortlik, Martin
    Hind'os, Miroslav
    Machkova, Nadezda
    Hruba, Veronika
    Lukas, Martin
    Zima, Tomas
    Lukas, Milan
    BIOLOGICALS, 2016, 44 (01) : 33 - 36
  • [43] Trough Concentration Response in Infliximab and Adalimumab Treated Children With Inflammatory Bowel Disease Following Treatment Adjustment: A Pharmacokinetic Model
    Levy, Rachel
    Matar, Manar
    Zvuloni, Maya
    Shamir, Raanan
    Assa, Amit
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2023, 76 (05): : 576 - 581
  • [44] Inflammatory bowel disease patients are frequently nonadherent to scheduled induction and maintenance infliximab therapy: A Canadian cohort study
    Ma, Christopher
    Evaschesen, Chad J.
    Gracias, Grenvil
    Huang, Vivian W.
    Fedorak, Darryl K.
    Kroeker, Karen I.
    Dieleman, Levinus A.
    Halloran, Brendan P.
    Fedorak, Richard N.
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 29 (06): : 309 - 314
  • [45] Efficacy of intravenous ustekinumab maintenance treatment in patients with Inflammatory Bowel Disease with partial response or loss of response to subcutaneous ustekinumab: A single centre, observational, retrospective study
    Pesantes, V. C. Jarrin
    Lozano, O. Moralejo
    Tercero, M. Abanades
    Perez, L. Ruano
    Luque, R. Salmoral
    Rosas, C. Munoz
    Rodriguez, R. A. Gomez
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1926 - i1928
  • [46] Higher serum infliximab concentrations during induction predict short-term endoscopic response in patients with inflammatory bowel disease
    Eberl, Anja
    Qadri, Sami
    Saavalainen, Paivi
    Sipponen, Taina
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (11) : 1125 - 1131
  • [47] Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy
    Sokol, Harry
    Seksik, Philippe
    Carrat, Fabrice
    Nion-Larmurier, Isabelle
    Vienne, Ariane
    Beaugerie, Laurent
    Cosnes, Jacques
    GUT, 2010, 59 (10) : 1363 - 1368
  • [48] Secondary Non-Immune Loss of Response to Long Term Maintenance Therapy With Infliximab for Inflammatory Bowel Disease is Not Due to Inadequate Trough Levels
    Farber, Michael J.
    Kohn, Nina
    Chua, Vincent
    Sultan, Keith S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S642 - S643
  • [49] Optimal Interval for Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease Receiving Stable Infliximab Maintenance Treatment
    Hong, S. N.
    Yujin, L.
    Boram, P.
    Soon, J. Ok
    Ho, K. Young
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I745 - I745
  • [50] Induction and Maintenance Infliximab Therapy for the Treatment of Crohn's Disease with Perianal Fistulas in Children: Retrospective, Multicenter Study
    Iwanczak, Barbara M.
    Ryzko, Jozef
    Jankowski, Piotr
    Sladek, Malgorzata
    Wasilewska, Agata
    Szczepanik, Mariusz
    Sienkiewicz, Edyta
    Szaflarska-Poplawska, Anna
    Wiecek, Sabina
    Kwiecien, Jaroslaw
    Korczowski, Bartosz
    Maslana, Jolanta
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 25 (03): : 523 - 530
12345